Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions

Brain NeoplasmLymphomaMetastatic Malignant Neoplasm in the BrainRecurrent Malignant Brain Neoplasm

Interventions

DRUG

Gadobenate Dimeglumine

Given IV

DRUG

Gadobutrol

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04132843 - Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions | Biotech Hunter | Biotech Hunter